Follicle-stimulating hormone receptor polymorphism (Thr307Ala) is associated with variable ovarian response and ovarian hyperstimulation syndrome in Indian women

Fertility and Sterility

Volumn 91, Issue 2, 2009, Pages 432-439

  Achrekar, Swati K ^a   Modi, Deepak N ^a   Desai, Sadhana K ^b   Mangoli, Vijay S ^b   Mangoli, Ranjana V ^b   Mahale, Smita D ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN REPRODUCTIVE HEALTH   (India)

^b Fertility Clinic   (India)

Author keywords

FSH; FSH receptor; FSH receptor polymorphisms; ovarian hyperstimulation syndrome; ovulation induction

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; FOLLITROPIN RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GENETIC POLYMORPHISM; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INDIAN; MAJOR CLINICAL STUDY; OVARY FUNCTION; OVARY HYPERSTIMULATION; OVULATION INDUCTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROSPECTIVE STUDY;

ADULT; DNA MUTATIONAL ANALYSIS; ESTRADIOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FERTILITY AGENTS, FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; ODDS RATIO; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION; OVULATION INDUCTION; PHENOTYPE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, FSH; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 59249091690     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.11.093     Document Type: Article

References (35)

1. Develioglu O.H., Cox B., Toner J.P., Oehninger S., and Muasher S.J. The value of basal serum follicle stimulating hormone, luteinizing hormone and oestradiol concentrations following pituitary down-regulation in predicting ovarian response to stimulation with highly purified follicle stimulating hormone. Hum Reprod 14 (1999) 1168-1174
2. Tinkanen H., Blauer M., Laippala P., Tuohimaa P., and Kujansuu E. Prognostic factors in controlled ovarian hyperstimulation. Fertil Steril 72 (1999) 932-936
3. Scott R.T., Leonardi M.R., Hofmann G.E., Illions E.H., Neal G.S., and Navot D. A prospective evaluation of clomiphene citrate challenge test screening of the general infertility population. Obstet Gynecol 82 (1993) 539-544
4. Scott Jr. R.T., and Hofmann G.E. Prognostic assessment of ovarian reserve. Fertil Steril 63 (1995) 1-11
5. Licciardi F.L., Liu H.C., and Rosenwaks Z. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril 64 (1995) 991-994
6. Barnhart K., and Osheroff J. Follicle stimulating hormone as a predictor of fertility. Curr Opin Obstet Gynecol 10 (1998) 227-232
7. Balasch J., Creus M., Fabregues F., Carmona F., Casamitjana R., Ascaso C., et al. Inhibin, follicle-stimulating hormone, and age as predictors of ovarian response in in vitro fertilization cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. Am J Obstet Gynecol 175 (1996) 1226-1230
8. Evers J.L., Slaats P., Land J.A., Dumoulin J.C., and Dunselman G.A. Elevated levels of basal estradiol-17beta predict poor response in patients with normal basal levels of follicle-stimulating hormone undergoing in vitro fertilization. Fertil Steril 69 (1998) 1010-1014
9. Hall J.E., Welt C.K., and Cramer D.W. Inhibin A and Inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod 14 (1999) 409-415
10. Dias J.A., Cohen B.D., Lindau-Shepard B., Nechamen C.A., Peterson A.J., and Schmidt A. Molecular, structural, and cellular biology of follitropin and follitropin receptor. Vitam Horm 64 (2002) 249-322
11. Means A.R., Dedman J.R., Tash J.S., Tindall D.J., van Sickle M., and Welsh M.J. Regulation of the testis Sertoli cell by follicle stimulating hormone. Annu Rev Physiol 42 (1980) 59-70
12. Simoni M., Gromoll J., and Nieschlag E. The follicle stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 18 (1997) 739-773
13. Themmen A.P.N., and Huhtaniemi I.T. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev 21 (2000) 551-583
14. Rannikko A., Pakarinen P., Manna P.R., Beau I., Misrahi M., Aittomaki K., et al. Functional characterization of the human FSH receptor with an inactivating Ala189Val mutation. Mol Hum Reprod 8 (2002) 311-317
15. Touraine P., Beau I., Gougeon A., Meduri G., Desroches A., Pichard C., et al. New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype. Mol Endocrinol 13 (1999) 1844-1854
16. Allen L.A., Achermann J.C., Pakarinen P., Kotlar T.J., Huhtaniemi I.T., Jameson J.L., et al. A novel loss of function mutation in exon 10 of the FSH receptor gene causing hypergondotrophic hypogonadism: clinical and molecular characteristics. Hum Reprod 18 (2003) 251-256
17. Doherty E., Pakarinen P., Tiitinen A., Kiilavuori A., Huhtaniemi I., Forrest S., et al. A novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure. J Clin Endocrinol Metab 87 (2002) 1151-1155
18. Meduri G., Touraine P., Beau I., Lahuna O., Desroches A., Vacher-Lavenu M.C., et al. Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological, and molecular studies. J Clin Endocrinol Metab 88 (2003) 3491-3498
19. Simoni M., Nieschlag E., and Gromoll J. Isoforms and single nucleotide polymorphisms of FSH receptor gene: implications for human reproduction. Hum Reprod Update 8 (2002) 413-421
20. Perez Mayorga M., Gromoll J., Behre H.M., Gassner C., Nieschlag E., and Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab 85 (2000) 3365-3369
21. Behre H.M., Greb R.R., Mempel A., Sonntag B., Kiesel L., Kaltwasser P., et al. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics 15 (2005) 451-456
22. Daelemans C., Smits G., de Maertelaer V., Costagliola S., Englert Y., Vassart G., et al. Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism. J Clin Endocrinol Metab 89 (2004) 6310-6315
23. Peter P.R. Ovarian follicular stimulation reigns in ART: the Bourn Hall Experience. In: Kamini R. (Ed). The Infertility Manual (2004), Jaypee (FOGSI) Publication, India 293-303
24. Sudo S., Kudo M., Wada S., Sato O., Hsueh A.J., and Fujimoto S. Genetic and functional analyses of polymorphism in the human FSH receptor gene. Mol Hum Reprod 8 (2002) 893-899
25. Laven J.S., Mulders A.G., Suryandari D.A., Gromoll J., Nieschlag E., Fauser B.C., et al. Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility. Fertil Steril 8 (2003) 986-992
26. Greb R.R., Grieshaber K., Gromoll J., Sonntag B., Nieschlag E., Kiesel L., et al. A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab 90 (2005) 4866-4872
27. Loutradis D., Patsoula E., Minas V., Koussidis G.A., Antsaklis A., Michalas S., et al. FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs. J Assist Reprod Genet 23 (2006) 177-184
28. Fauser B.C., Devroey P., Yen S.S., Gosden R., Crowley Jr. W.F., Baird D.T., et al. Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. Hum Reprod 14 (1999) 2681-2686
29. Elchalal U., and Schenker J.G. The pathophysiology of ovarian hyperstimulation syndrome-views and ideas. Hum Reprod 12 (1997) 1129-1137
30. d'Alva C.B., Serafini P., Motta E., Kohek M.B., Latronico A.C., and Mendonca B.B. Absence of follicle-stimulating hormone receptor activating mutations in women with iatrogenic ovarian hyperstimulation syndrome. Fertil Steril 83 (2005) 1695-1699
31. Kerkela E., Skottman H., Friden B., Bjuresten K., Kere J., and Hovatta O. Exclusion of coding-region mutations in luteinizing hormone and follicle-stimulating hormone receptor genes as the cause of ovarian hyperstimulation syndrome. Fertile Steril 87 (2007) 603-606
32. Kene P.S., Nalavadi V.C., Dighe R.R., Iyer K.S., and Mahale S.D. Identification of structural and functional determinants of the extracellular domain of the human follicle stimulating hormone receptor. J Endocrinol 182 (2004) 501-508
33. Kene P.S., Dighe R.R., and Mahale S.D. Delineation of regions in the extracellular domain of follicle-stimulating hormone receptor involved in hormone binding and signal transduction. Am J Reprod Immunol 54 (2005) 38-48
34. Ryan G.L., Feng X., d'Alva C.B., Zhang M., Van Voorhis B.J., Pinto E.M., et al. Evaluating the roles of follicle-stimulating hormone receptor polymorphisms in gonadal hyperstimulation associated with sever juveile primary hypothyrodism. J Clin Endocrinol Metab 92 (2007) 2312-2317
35. Klinkert E.R., te Velde E.R., Weima S., van Zandvoort P.M., Hanssen R.G., Nilsson P.R., et al. FSH receptor genotype is associated with pregnancy but not with ovarian response in IVF. Reprod Biomed Online 13 (2006) 687-695